ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Pharmaceutical Pricing Policy: A Critique

The recently announced draft National Pharmaceutical Pricing Policy 2011 fails to ensure accessible and affordable medicines for all in India. This is due to the limited scope and market-based approach it offers to price control. Among other measures, policy should fix ceiling prices based on lowest priced alternatives instead of high-priced top sellers, aim to revive pharmaceutical public sector undertakings, and expand the current National List of Essential Medicines. Most importantly, pharmaceuticals must be brought under the remit of the Ministry of Health and Family Welfare to allow better coordination for public health interests.



Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

649for India

$20for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top